Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas André

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Pediatric Blood & Cancer|December 10, 2022
Comment on: Irinotecan dose schedule for the treatment of Ewing sarcoma-protracted/metronomic schedule-wording matters!Nicolas André
The Lancet. Oncology|October 5, 2023
Common Sense Oncology: including everyoneNicolas André
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Decisional priority in pediatric oncology revisited: involving children in decision makingNicolas André
Lancet (London, England)|April 18, 2003
Hippocrates of Cos and apoptosisNicolas André
The Lancet. Oncology|August 4, 2004
Involving children in paediatric oncology decision-makingNicolas André
Pediatric Blood & Cancer|July 4, 2020
Covid-19: Breaking bad news with social distancing in pediatric oncologyNicolas André
Current Cancer Drug Targets|February 4, 2011
New therapeutic advances and perspectives in tumour angiogenesisEddy Pasquier, Nicolas André
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 8, 2010
Can the drug-driven dependency and deprivation effect be used as a therapeutic tool in tuberculous patients?Nicolas André, Eddy Pasquier
Frontiers in Medicine|July 24, 2019
Editorial: Drug RepurposingPan Pantziarka, Nicolas André
Nature Clinical Practice. Oncology|January 31, 2009
Response to 'Intermittent androgen blockade should be regarded as standard therapy in prostate cancer'Nicolas André, Eddy Pasquier
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Pediatric Blood & Cancer|December 10, 2022
Comment on: Irinotecan dose schedule for the treatment of Ewing sarcoma-protracted/metronomic schedule-wording matters!Nicolas André
The Lancet. Oncology|October 5, 2023
Common Sense Oncology: including everyoneNicolas André
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Decisional priority in pediatric oncology revisited: involving children in decision makingNicolas André
Lancet (London, England)|April 18, 2003
Hippocrates of Cos and apoptosisNicolas André
The Lancet. Oncology|August 4, 2004
Involving children in paediatric oncology decision-makingNicolas André
Pediatric Blood & Cancer|July 4, 2020
Covid-19: Breaking bad news with social distancing in pediatric oncologyNicolas André
Current Cancer Drug Targets|February 4, 2011
New therapeutic advances and perspectives in tumour angiogenesisEddy Pasquier, Nicolas André
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 8, 2010
Can the drug-driven dependency and deprivation effect be used as a therapeutic tool in tuberculous patients?Nicolas André, Eddy Pasquier
Frontiers in Medicine|July 24, 2019
Editorial: Drug RepurposingPan Pantziarka, Nicolas André
Nature Clinical Practice. Oncology|January 31, 2009
Response to 'Intermittent androgen blockade should be regarded as standard therapy in prostate cancer'Nicolas André, Eddy Pasquier
Pageof 21